Dopamine D2/D3 Receptors in Compulsive Disorders
强迫症中的多巴胺 D2/D3 受体
基本信息
- 批准号:7935212
- 负责人:
- 金额:$ 46.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AgonistAnimal ModelBehaviorBehavior TherapyBehavioralBehavioral ModelCocaineDataDiseaseDopamineDopamine AgonistsDopamine ReceptorEatingElementsEvaluationExerciseGamblingGoalsHome environmentIndividualInterventionModelingNatureObsessive compulsive behaviorOperant ConditioningOrganismPharmaceutical PreparationsPharmacological TreatmentPositioning AttributePrevention approachProceduresProcessPsychopathologyQuinpiroleRNA InterferenceRattusResearchRespondentRodentRoleSex BehaviorStimulusTestingThinkingTimeWaterbehavioral pharmacologychemical synthesisconditioningdesignexcessive behaviorneurochemistryprogramspublic health relevancereceptorreinforced behaviorreinforcersextherapy development
项目摘要
DESCRIPTION (provided by applicant): Compulsive behaviors, including excessive eating, gambling, shopping, exercising, or drug-taking, can develop over time in individuals without other psychopathology. Although compulsive behavior is marked by excessive engagement in a particular behavior, animal models of compulsive behavior suggest that another defining feature is behavior that is disconnected from reinforcer delivery. Thus, people may gamble compulsively even though they do not win often, or shop excessively even when they may not use what they have purchased. Our hypothesis is that these types of reinforcer- disconnected behaviors result when both operant (instrumental, goal-tracking) and respondent (Pavlovian, classical, sign-tracking) conditioning processes converge on the same behavior. In addition, individuals must be sensitized to dopamine, and the compulsive behavior is more likely to occur in the presence of a D3/D2 agonist acting on the sensitized dopamine receptors. We will test this hypothesis in three behavioral models: 1) quinpirole-induced responding for stimuli associated with cocaine; 2) quinpirole-induced responding for water in the presence of water; and 3) quinpirole as an occasion setter for either cocaine or water-reinforced behavior. The behavioral pharmacology of these models will be tested with various dopamine agonists and antagonists, and the roles of sensitization, goal-tracking, and sign-tracking will be studied. Understanding the environmental, behavioral, neurochemical, and pharmacological aspects of compulsive disorders will hopefully contribute to the development of treatments for these debilitating disorders. PUBLIC HEALTH RELEVANCE: The purpose of this proposal is to determine various environmental and neurochemical contributors to compulsive behavior (e.g., excessive gambling, shopping, eating, sexual behavior, and drug-taking). Our hypothesis, that compulsions result when the same classically conditioned and operantly conditioned behavior is established in the presence of sensitized dopamine receptors and stimulation of dopamine receptors, will be tested in three rat models in this research effort. Evaluation of the ability of selective dopamine receptors, as well as silencing the RNA for the D3 receptor, to modify the compulsive behavior should help point towards possible pharmacological treatment of these disorders, and understanding of the setting conditions will suggest behavioral therapy and prevention approaches.
描述(由申请人提供):强迫行为,包括过度饮食,赌博,购物,锻炼或吸毒,可以随着时间的流逝而在没有其他心理病理学的个人中发展。尽管强迫性行为以特定行为的过度参与为特征,但强迫行为的动物模型表明,另一个定义特征是与加强剂传递断开连接的行为。因此,即使人们不经常获胜,也可能会强迫赌博,或者即使可能不使用自己购买的商品,他们也会过度购物。我们的假设是,当操作者(工具,目标跟踪)和受访者(Pavlovian,Pavlovian,经典,签名)调理过程都会融合相同的行为时,这些类型的增强器断开行为会产生。另外,必须将个体敏感到多巴胺,并且在作用于敏化多巴胺受体的D3/D2激动剂存在下,强迫性行为更有可能发生。我们将在三个行为模型中检验这一假设:1)奎因螺氏诱导的与可卡因相关的刺激的反应; 2)在水存在下,奎因螺染引起的水反应; 3)作为可卡因或强力行为的Quinpipole作为场合。这些模型的行为药理学将与各种多巴胺激动剂和拮抗剂一起测试,并将研究致敏,目标跟踪和标志跟踪的作用。了解强迫症的环境,行为,神经化学和药理方面,有望有助于为这些令人衰弱的疾病的治疗发展。公共卫生相关性:该提案的目的是确定强迫行为的各种环境和神经化学贡献者(例如,过多的赌博,购物,饮食,性行为和吸毒)。我们的假设是,在这项研究工作中,将在三个大鼠模型中测试,在存在敏化多巴胺受体的情况下建立相同的经典条件和操作的行为并刺激多巴胺受体的刺激。评估选择性多巴胺受体的能力,以及对D3受体的RNA进行沉默,以修改强迫性行为,应有助于指出可能对这些疾病的药理学治疗,对设置条件的了解将暗示行为治疗和预防方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
james H Woods其他文献
james H Woods的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('james H Woods', 18)}}的其他基金
Preclinical Identification of Better Antimuscarinic Antidepressants
更好的抗毒蕈碱抗抑郁药的临床前鉴定
- 批准号:
9521089 - 财政年份:2017
- 资助金额:
$ 46.62万 - 项目类别:
Preclinical Identification of Better Antimuscarinic Antidepressants
更好的抗毒蕈碱抗抑郁药的临床前鉴定
- 批准号:
9106052 - 财政年份:2016
- 资助金额:
$ 46.62万 - 项目类别:
Dopamine D2/D3 Receptors in Compulsive Disorders
强迫症中的多巴胺 D2/D3 受体
- 批准号:
7728111 - 财政年份:2009
- 资助金额:
$ 46.62万 - 项目类别:
Dopamine D2/D3 Receptors in Compulsive Disorders
强迫症中的多巴胺 D2/D3 受体
- 批准号:
8107619 - 财政年份:2009
- 资助金额:
$ 46.62万 - 项目类别:
Dopamine D2/D3 Receptors in Compulsive Disorders
强迫症中的多巴胺 D2/D3 受体
- 批准号:
8289580 - 财政年份:2009
- 资助金额:
$ 46.62万 - 项目类别:
Development of Esterases for the Treatment of Cocaine Overdose and Abuse
开发用于治疗可卡因过量和滥用的酯酶
- 批准号:
7079791 - 财政年份:2006
- 资助金额:
$ 46.62万 - 项目类别:
Development of Esterases for the Treatment of Cocaine Overdose and Abuse
开发用于治疗可卡因过量和滥用的酯酶
- 批准号:
7228552 - 财政年份:2006
- 资助金额:
$ 46.62万 - 项目类别:
Development of Esterases for the Treatment of Cocaine Overdose and Abuse
开发用于治疗可卡因过量和滥用的酯酶
- 批准号:
7407488 - 财政年份:2006
- 资助金额:
$ 46.62万 - 项目类别:
Development of Esterases for the Treatment of Cocaine Overdose and Abuse
开发用于治疗可卡因过量和滥用的酯酶
- 批准号:
7615518 - 财政年份:2006
- 资助金额:
$ 46.62万 - 项目类别:
Stress, Rearing, and Ethanol Reinforcement in Monkeys
猴子的压力、饲养和乙醇强化
- 批准号:
6807568 - 财政年份:2003
- 资助金额:
$ 46.62万 - 项目类别:
相似国自然基金
低氧诱导的外泌体OTUB1调控血管瘤内皮细胞生物学行为的作用及机制研究
- 批准号:81901022
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
自闭症动物模型嗅觉恐惧反应异常的神经环路解析
- 批准号:31900715
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
高脂饮食促进果蝇和大鼠觅食行为的神经机制研究
- 批准号:31800883
- 批准年份:2018
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
NRSF表达水平对抑郁模型小鼠行为的影响及其分子机制研究
- 批准号:81801333
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于eNOS功能障碍创建可逆性脑血管收缩综合征(RCVS)小鼠模型的研究
- 批准号:81873753
- 批准年份:2018
- 资助金额:81.0 万元
- 项目类别:面上项目
相似海外基金
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 46.62万 - 项目类别:
PPARdelta receptors and alcohol use phenotypes
PPARδ 受体和饮酒表型
- 批准号:
10682348 - 财政年份:2023
- 资助金额:
$ 46.62万 - 项目类别:
Targeting the allosteric sodium site with novel probes for delta opioid receptor
用新型 δ 阿片受体探针靶向变构钠位点
- 批准号:
10892532 - 财政年份:2023
- 资助金额:
$ 46.62万 - 项目类别:
A Nonhuman Primate Model for Postoperative Delirium and Working Memory Impairment
术后谵妄和工作记忆损伤的非人类灵长类动物模型
- 批准号:
10592515 - 财政年份:2023
- 资助金额:
$ 46.62万 - 项目类别: